The Bulletin
Men's Weekly


.

TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer

  • Written by PR Newswire
TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer
  • TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab
  • TU2218 demonstrated a favorable safety and a synergetic effect with immuno-oncology drugs in preclinical studies

BOSTON and SEONGNAM, South Korea, March 11, 2024 /PRNewswire/ -- TiumBio Co., Ltd. (KOSDAQ: 321550), a clinical-stage biopharmaceutical...

The Bulletin Magazine

Why Body Contouring Melbourne Treatments Are Increasingly Popular for Shape Refinement

Skip Hire Melbourne Services for Efficient and Responsible Waste Disposal

Why Commercial Scaffolding Services Are Critical for Large Scale Projects

Sydney Suburban Living: Combining Style, Security and Functionality

Professional Assistance to a successful Australian relocation

What is a vendor advocate?

Understanding The Benefits Of A Sleep Apnea Mask For Effective Therapy

The Importance Of A 24 Hour Emergency Electrician For Fast And Safe Electrical Response

The Importance Of Vehicle Protection With Bash Plates And Underbody Upgrades

How to Find the Best Off Road Caravans for Australian Adventures

How Rims And Tyres For Sale Sydney Improve Performance, Safety And Driving Confidence

How Huggies Nappies Support Comfort, Absorption And Protection For Babies Of All Ages